NEW YORK (
CHANGE IN RATINGS
(ARO - Get Report) upgraded at Wedbush to Outperform from Neutral, Wedbush said. $26 price target. Early signs of better women's products.
(APOL) downgraded to hold at TheStreet Ratings.
(DTV - Get Report) upgraded at Citigroup to Buy from Neutral, Citigroup said. $59 price target. Low LatAm FCF presents opportunity, not risk.
(FFIV - Get Report)
downgraded at FBN from Outperform to Sector Perform, FBN Securities said. Valuation call, based on a $135 price target.
upgraded at Sterne Agee from Underperform to Neutral, Sterne Agee said. Valuation call, based on an $11 price target.
downgraded to sell at TheStreet Ratings.
downgraded at Citigroup to Neutral from Buy, Citigroup said. $53 price target. Valuation call.
upgraded at JMP from Underperform to Market Perform, JMP Securities said. Margin and booking trends appear to be bottoming.
downgraded at Stifel from Hold to Sell, Stifel Nicolaus said. Company is losing market share and consensus expectations appear overly optimistic.
upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $26 price target. Growth should accelerate in the coming quarters.
upgraded at Jefferies from Hold to Buy, Jefferies said. $32.50 price target. Partnership deals can help drive accelerated growth.
downgraded at Guggenheim from Buy to Neutral, Guggenheim said. $17 price target. Estimates also cut, given pressures in the frac market.
STOCK COMMENTS / EPS CHANGES
target increased at UBS to $27, UBS said. Company will potentially announce steps to streamline its cost structure. Neutral rating.
Capital One Financial
target raised at Citigroup to $66, Citigroup said. Card fundamentals remain healthy. Buy rating.
numbers raised at Canaccord. Shares of CRM now seen reaching $180, according to Canaccord Genuity. Estimates also increased, given the company's strong growth momentum. Buy rating.
estimates, target boosted at Morgan Stanley. Shares of EMC now seen reaching $37, according to Morgan Stanley. Estimates also upped, given a better product mix. Overweight rating.
target boosted at Oppenheimer. Shares of GE now seen reaching $24, according to Oppenheimer. Company is leveraged to a cyclical recovery. Outperform rating.